TIE2/PIK3CA PATHWAY DRIVEN VASCULAR ANOMALIES

Clinical trials for TIE2/PIK3CA PATHWAY DRIVEN VASCULAR ANOMALIES explained in plain language.

Never miss a new study

Get alerted when new TIE2/PIK3CA PATHWAY DRIVEN VASCULAR ANOMALIES trials appear

Sign up with your email to follow new studies for TIE2/PIK3CA PATHWAY DRIVEN VASCULAR ANOMALIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Cancer drug shows promise for rare blood vessel disorders in kids and young adults

Disease control Ongoing

This study tests the drug alpelisib (approved for breast cancer) in people aged 2 to 30 with certain genetic blood vessel growth disorders. Participants take the drug for at least 2 years and attend up to 16 clinic visits to check if their condition improves. The goal is to see i…

Matched conditions: TIE2/PIK3CA PATHWAY DRIVEN VASCULAR ANOMALIES

Phase: PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control

Last updated May 26, 2026 10:24 UTC

TIE2/PIK3CA PATHWAY DRIVEN VASCULAR ANOMALIES

Get alerted when new TIE2/PIK3CA PATHWAY DRIVEN VASCULAR ANOMALIES trials appear

Cancer drug shows promise for rare blood vessel disorders in kids and young adults